Literature DB >> 8866725

Hypolipidaemic effect of fruit juice of Emblica officinalis in cholesterol-fed rabbits.

R Mathur1, A Sharma, V P Dixit, M Varma.   

Abstract

The lipid lowering and antiatherosclerotic effects of Emblica officinalis (Amla) fresh juice were evaluated in cholesterol-fed rabbits (rendered hyperlipidaemic by atherogenic diet and cholesterol feeding). E. officinalis fresh juice was administered at a dose of 5 ml/kg body weight per rabbit per day for 60 days. Serum cholesterol, TG, phospholipid and LDL levels were lowered by 82%, 66%, 77% and 90%, respectively. Similarly, the tissue lipid levels showed a significant reduction following E. officinalis juice administration. Aortic plaques were regressed. E. officinalis juice treated rabbits excreted more cholesterol and phospholipids, suggesting that the mode of absorption was affected. E. officinalis juice is an effective hypolipidaemic agent and can be used as a pharmaceutical tool in hyperlipidaemic subjects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866725     DOI: 10.1016/0378-8741(95)01308-3

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  11 in total

1.  A Pilot clinical study to evaluate the effect of Emblica officinalis extract (Amlamax™) on markers of systemic inflammation and dyslipidemia.

Authors:  B Antony; M Benny; T N B Kaimal
Journal:  Indian J Clin Biochem       Date:  2008-12-20

2.  Evaluation of anticataract potential of Triphala in selenite-induced cataract: In vitro and in vivo studies.

Authors:  Suresh Kumar Gupta; V Kalaiselvan; Sushma Srivastava; Shyam S Agrawal; Rohit Saxena
Journal:  J Ayurveda Integr Med       Date:  2010-10

3.  A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin.

Authors:  Biswas Gopa; Jagatkumar Bhatt; Kovur G Hemavathi
Journal:  Indian J Pharmacol       Date:  2012-03       Impact factor: 1.200

Review 4.  Therapeutic potential of traditional chinese medicine on inflammatory diseases.

Authors:  Wen-Hsin Tsai; Chih-Ching Yang; Ping-Chia Li; Wang-Chuan Chen; Chiang-Ting Chien
Journal:  J Tradit Complement Med       Date:  2013-07

Review 5.  Immunomodulatory effects of triphala and its individual constituents: a review.

Authors:  Pranoti Belapurkar; Pragya Goyal; Preeti Tiwari-Barua
Journal:  Indian J Pharm Sci       Date:  2014 Nov-Dec       Impact factor: 0.975

6.  Hypolipidemic, antioxidant and anti-atherosclerogenic effect of aqueous extract leaves of Cassia. occidentalis Linn (Caesalpiniaceae) in diet-induced hypercholesterolemic rats.

Authors:  Ntchapda Fidèle; Barama Joseph; Talla Emmanuel; Dimo Théophile
Journal:  BMC Complement Altern Med       Date:  2017-01-25       Impact factor: 3.659

7.  Amlamax in the management of dyslipidemia in humans.

Authors:  B Antony; B Merina; V Sheeba
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

8.  Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study.

Authors:  Pingali Usharani; Nishat Fatima; Nizampatnam Muralidhar
Journal:  Diabetes Metab Syndr Obes       Date:  2013-07-26       Impact factor: 3.168

Review 9.  Triphala: current applications and new perspectives on the treatment of functional gastrointestinal disorders.

Authors:  Aleksandra Tarasiuk; Paula Mosińska; Jakub Fichna
Journal:  Chin Med       Date:  2018-07-18       Impact factor: 5.455

Review 10.  A systematic review on the cardiovascular pharmacology of Emblica officinalis Gaertn.

Authors:  Fataneh Hashem-Dabaghian; Mojtaba Ziaee; Samad Ghaffari; Farzaneh Nabati; Saeed Kianbakht
Journal:  J Cardiovasc Thorac Res       Date:  2018-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.